These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12769338)

  • 21. Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies.
    Nenova IS; Goranov SE; Mateva NG; Ananoshtev NH
    Folia Med (Plovdiv); 2003; 45(1):13-9. PubMed ID: 12943062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
    Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
    Engervall PA; Stiernstedt GT; Günther GC; Björkholm MJ
    J Chemother; 1992 Apr; 4(2):99-106. PubMed ID: 1629753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
    Engervall P; Günther G; Ljungman P; Lönnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Björkholm M
    J Chemother; 1996 Oct; 8(5):382-6. PubMed ID: 8957719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
    Petrilli AS; Melaragno R; Barros KV; Silva AA; Kusano E; Ribeiro RC; Bianchi A
    Pediatr Infect Dis J; 1993 Nov; 12(11):916-21. PubMed ID: 8265281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
    Kleinhendler E; Cohen MJ; Moses AE; Paltiel O; Strahilevitz J; Cahan A
    Int J Antimicrob Agents; 2018 Jan; 51(1):71-76. PubMed ID: 28705670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
    Raad II; Abi-Said D; Rolston KV; Karl CL; Bodey GP
    Cancer; 1998 Jun; 82(12):2449-58. PubMed ID: 9635539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
    Nakane T; Tamura K; Hino M; Tamaki T; Yoshida I; Fukushima T; Tatsumi Y; Nakagawa Y; Hatanaka K; Takahashi T; Akiyama N; Tanimoto M; Ohyashiki K; Urabe A; Masaoka T; Kanamaru A;
    J Infect Chemother; 2015 Jan; 21(1):16-22. PubMed ID: 25239059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
    Ozyilkan O; Yalçintaş U; Başkan S
    Korean J Intern Med; 1999 Jul; 14(2):15-9. PubMed ID: 10461420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.
    Cometta A; Glauser MP
    J Chemother; 1996 Oct; 8(5):375-81. PubMed ID: 8957718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.
    Lehrnbecher T; Stanescu A; Kühl J
    Infection; 2002 Jan; 30(1):17-21. PubMed ID: 11876510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of febrile neutropenia with cefepime monotherapy.
    Jándula BM; Martino R; Gurgi M; Manteiga R; Sierra J
    Chemotherapy; 2001; 47(3):226-31. PubMed ID: 11306793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
    Matsui K; Masuda N; Takada M; Kusunoki Y; Fukuoka M
    Jpn J Clin Oncol; 1991 Dec; 21(6):428-34. PubMed ID: 1805048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.
    Horita N; Shibata Y; Watanabe H; Namkoong H; Kaneko T
    Clin Microbiol Infect; 2017 Oct; 23(10):723-729. PubMed ID: 28377312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.
    Chernobelski P; Lavrenkov K; Rimar D; Riesenberg K; Schlaeffer F; Ariad S; Mermershtain W
    Chemotherapy; 2006; 52(4):185-9. PubMed ID: 16675902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.